Healey, J. S., Lopes, R. D. S., Granger, C., Alings, M., Birnie, D. H., Benezet-Mazuecos, J., … Connolly, S. J. (2023). Apixaban for the Prevention of Stroke in Patients With Subclinical Atrial Fibrillation. In CIRCULATION (Vol. 148, pp. E290–E290).

Healey, Jeff S., Renato D Sr Lopes, Christopher Granger, Marco Alings, David H. Birnie, Juan Benezet-Mazuecos, Jens Cosedis Nielsen, et al. “Apixaban for the Prevention of Stroke in Patients With Subclinical Atrial Fibrillation.” In CIRCULATION, 148:E290–E290, 2023.

Healey JS, Lopes RDS, Granger C, Alings M, Birnie DH, Benezet-Mazuecos J, et al. Apixaban for the Prevention of Stroke in Patients With Subclinical Atrial Fibrillation. In: CIRCULATION. 2023. p. E290–E290.

Healey, Jeff S., et al. “Apixaban for the Prevention of Stroke in Patients With Subclinical Atrial Fibrillation.” CIRCULATION, vol. 148, no. 25, 2023, pp. E290–E290.

Healey JS, Lopes RDS, Granger C, Alings M, Birnie DH, Benezet-Mazuecos J, Nielsen JC, Boriani G, Mairesse G, Hohnloser SH, Philippon F, Kutyifa V, Gold MR, Linde CM, Conen D, Erath J, Mabo P, Sticherling C, Wright D, McIntyre WF, Atar D, Mian R, Xu L, Rivard L, Kautzner J, Proietti M, Camm AJ, Aronson R, Zarraga I, Ip J, Connolly SJ. Apixaban for the Prevention of Stroke in Patients With Subclinical Atrial Fibrillation. CIRCULATION. 2023. p. E290–E290.